Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001387131-16-005405)

Filing Details

Accession Number:: 0001387131-16-005405
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-05-11 16:32:41
Reporting Period:: 2016-05-09

Filing Date:: 2016-05-11
Accepted Time:: 2016-05-11 16:32:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
887247	Adamis Pharmaceuticals Corp	ADMP	Pharmaceutical Preparations (2834)	820429727

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1461753	J. David Marguglio	C/O Adamis Pharmaceuticals Corporation 11682 El Camino Real, Suite 300 San Diego, CA 92130	Sr Vp Of Corporate Development	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-05-09	4,860	$10.00	106,227	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted in September 2015.